Hi, help us enhance your experience
Hi, help us enhance your experience
Hi, help us enhance your experience
768 Views
eMediNexus 24 June 2021
Coronavirus Cases: 180,350,950
Deaths: 3,907,028
Recovered: 165,074,339
ACTIVE CASES: 11,369,583
Serious/Critical Cases: 81,566
(Source: https://www.worldometers.info/coronavirus/; June 23, 2021)
# | Country,Other | TotalCases | NewCases | TotalDeaths | NewDeaths | TotalRecovered | NewRecovered | ActiveCases | Serious,Critical | Tot Cases/1M pop | Deaths/1M pop | TotalTests | Tests/1M pop | Population |
World | 180,350,950 | +430,348 | 3,907,028 | +8,701 | 165,074,339 | +396,311 | 11,369,583 | 81,566 | 23,137 | 501.2 | ||||
1 | 34,449,004 | +12,942 | 618,294 | +326 | 28,846,304 | +24,529 | 4,984,406 | 3,925 | 103,482 | 1,857 | 501,368,853 | 1,506,077 | ||
2 | 30,082,169 | +54,319 | 392,014 | +978 | 29,056,609 | +69,298 | 633,546 | 8,944 | 21,592 | 281 | 395,973,198 | 284,211 | ||
3 | 18,170,778 | +114,139 | 507,240 | +2,343 | 16,483,635 | +94,788 | 1,179,903 | 8,318 | 84,897 | 2,370 | 52,820,657 | 246,786 | ||
4 | 5,762,322 | +2,320 | 110,862 | +33 | 5,583,247 | +8,110 | 68,213 | 1,509 | 88,089 | 1,695 | 91,430,049 | 1,397,701 | ||
5 | 5,387,545 | +5,809 | 49,358 | +65 | 5,248,862 | +5,917 | 89,325 | 763 | 63,216 | 579 | 59,221,265 | 694,891 | ||
6 | 5,368,513 | +17,594 | 130,895 | +548 | 4,902,110 | +12,660 | 335,508 | 2,300 | 36,772 | 897 | 146,400,000 | 1,002,770 | ||
7 | 4,667,870 | +16,135 | 128,027 | +19 | 4,308,504 | +2,022 | 231,339 | 250 | 68,410 | 1,876 | 204,758,457 | 3,000,821 | ||
8 | 4,326,101 | +27,319 | 90,986 | +705 | 3,944,323 | +15,934 | 290,792 | 7,241 | 94,870 | 1,995 | 16,071,070 | 352,434 | ||
9 | 4,255,434 | +951 | 127,352 | +30 | 4,059,463 | +5,455 | 68,619 | 344 | 70,483 | 2,109 | 70,388,886 | 1,165,863 | ||
10 | 4,027,016 | +29,995 | 101,947 | +645 | 3,741,459 | +26,497 | 183,610 | 8,155 | 78,329 | 1,983 | 19,168,055 | 372,835 |
(Source: https://www.worldometers.info/coronavirus/; June 23, 2021)
India Scenario
23rd June: New Cases 54319, New Deaths 978, Total Cases 30082169, Total Deaths 392014, Active Cases 633546
22nd June: New Cases 54393, New Deaths 1129, Total Cases 30027850, Total Deaths 390691, Active Cases 649848
21st June: New Cases 39096, New Deaths 846, Total Cases 29973457, Total Deaths 389268, Active Cases 670998
20th June: New Cases 53009, New Deaths 1113, Total Cases 29934361, Total Deaths 388164, Active Cases 709668
19th June: New Cases 58588, New Deaths 1239, Total Cases 29881352, Total Deaths 386740, Active Cases 736165
18th June: New Cases 60800, New Deaths 1269, Total Cases 29822764, Total Deaths 385167, Active Cases 766718
17th June: New Cases 62409, New Deaths 1310, Total Cases 29761964, Total Deaths 383521, Active Cases 805422
16th June: New Cases 67294, New Deaths 1411, Total Cases 29699555, Total Deaths 381931, Active Cases 833080
15th June: New Cases 62226, New Deaths 1470, Total Cases 29632261, Total Deaths 379601 (including backlog), Active Cases 872026
14th June: New Cases 62597, New Deaths 1452, Total Cases 29570035, Total Deaths 377061 (including backlog), Active Cases 920194
13th June: New Cases 68400, New Deaths 1761, Total Cases 29507438, Total Deaths 374287 (including backlog), Active Cases 984174
12th June: New Cases 81005, New Deaths 1830, Total Cases 29439038, Total Deaths 372526 (including backlog), Active Cases 1032745
11th June: New Cases 84695, New Deaths 4000, Total Cases 29358033, Total Deaths 367097, Active Cases 1089248
10th June: New Cases 91266, New Deaths 3402, Total Cases 29273338, Total Deaths 363097, Active Cases 1131347
9th June: New Cases 93896, New Deaths 6138 , Total Cases 29182072, Total Deaths 359695, Active Cases 1177152
8th June: New Cases 91227, New Deaths 2213 , Total Cases 29088176, Total Deaths 353557, Active Cases 1238421
7th June: New Cases 87345, New Deaths 2115 , Total Cases 28996949, Total Deaths 351344, Active Cases 1308806
6th June: New Cases 101232, New Deaths 2445, Total Cases 28909604, Total Deaths 349229, Active Cases 1409648
5th June: New Cases 114537, New Deaths 2683, Total Cases 28808372, Total Deaths 346784, Active Cases 1484977
4th June: New Cases 121476, New Deaths 3382, Total Cases 28693835, Total Deaths 344101, Active Cases 1562604
3rd June: New Cases 131371, New Deaths 2706, Total Cases 28572359, Total Deaths 340719, Active Cases 1642832
2nd June: New Cases 134105, New Deaths 2899, Total Cases 28440988, Total Deaths 338013 , Active Cases 1720078
1st June: New Cases 133228, New Deaths 3205, Total Cases 28306883, Total Deaths 335114, Active Cases 1800777
(Source: https://www.worldometers.info/coronavirus/)
Cases
COVID-19 Variants
SARS-CoV-2 Variants of Concern
New WHO Label | Pango lineage | GISAID clade/lineage
| Next strain clade | Earliest documented samples
| Date of designation | Key mutations in spike protein |
Alpha | B.1.1.7 | GRY (formerly GR/501Y.V1) | 20I (V1) | UK, September 2020 | 18th December, 2020 | N501Y (RBD), 69/70 deletion, 144Y deletion, P681H (S1/S2 furin cleavage site |
Beta | B.1.351 | GR/501Y.V2 | 20H (V2) | South Africa, May 2020 | 18th December, 2020 | N501Y, K417N, E484K, 241/242/243 deletion |
Gamma | P1 | GR/501Y.V3 | 20J (V1) | Brazil, November 2020 | 11th January, 2021 | N501Y, K417T, E484K |
Delta* | B.1.617.2 | G/478K.V1 | 21A | India, October 2020 | 4th April, 2021 (VOI) 11th May, 2021 (VOC) | E484Q, L452R |
(Source: WHO)
* A new “Delta plus” variant (B.1.617.2.1 or AY.1) has been formed due to a new mutation K417N in the Delta variant. The Union Health Ministry has said that the Delta Plus variant is now a Variant of Concern in India.
SARS-CoV-2 Variants of Interest
New WHO Label | Pango lineage | GISAID clade/lineage
| Next strain clade | Earliest documented samples
| Date of designation |
Epsilon | B.1.427/B.1.429 | GH/452R.V1 | 21C | California USA, March 2020 | 5th March, 2021 |
Zeta | P.2 | GR/484K.V2 | 20B/S.484K | Brazil, April 2020 | 17th March, 2021 |
Eta | B.1.525 | G/484K.V3 | 21D | Multiple countries, December 2020 | 17th March, 2021 |
Theta | P.3 | GR/1092K.V1 | 21E | Philippines, January 2021 | 24th March, 2021 |
Iota | B.1.526 | GH/253G.V1 | 21F | New York USA, November 2020 | 24th March, 2021 |
Kappa | B.1.617.1 | G/452R.V3 | 21B | India, October 2020 | 4th April, 2021 |
Lambda | C.37 | G/452Q.V1 | 20D | Peru, August 2020 | 14th June, 2021 |
(Source: WHO)
Hybrid of Indian and UK COVID-19 variants: Vietnam has uncovered a new Covid-19 variant combining characteristics of the two existing variants first found in India and the UK, which can spread quickly by air. The concentration of virus in the throat fluid increases rapidly and spreads very strongly to the surrounding environment. The WHO has said that there is no new hybrid strain. The strain detected in Vietnam is part of delta strain first detected in India.
Some consequences of emerging variants
Variants of concern might require one or more appropriate public health actions, such as notification to WHO under the International Health Regulations, reporting to CDC, local or regional efforts to control spread, increased testing, or research to determine the effectiveness of vaccines and treatments against the variant. Based on the characteristics of the variant, additional considerations may include the development of new diagnostics or the modification of vaccines or treatments (CDC).
India predictions: Formulas for better understanding of data
COVID Sutra
COVID-19 pandemic is due to SARS 2 Beta-coronavirus (different from SARS 1 where spread was only in serious cases); Causes mild or atypical illness in 82%, moderate to severe illness in 15%, critical illness in 3% and death in 2.3% cases (15% of admitted serious cases, 71% with comorbidity< Male > Females); affects all but predominantly males (56%, 87% aged 30-79, 10% aged < 20, 3% aged > 80); with variable incubation period days (2-14; mean 5.2 days); mean time to symptoms 5 days; mean time to pneumonia 9 days, mean time to death 14 days, Mean Time to CT changes 4 Days, Reproductive Number R0 1.5 to 3 (Flu 1.2 and SARS 2), Origin Possibly from Bats (Mammal); spreads through the air (by inhalation of air carrying very small fine droplets and aerosol particles, human to human transmission via large and small droplets or touching inanimate surfaces contaminated with virus . Enters through MM of eyes, nose or mouth and the spike protein gets attached to the ACE2 receptors, which are found in organs throughout the body (heart muscle, CNS, kidneys, blood vessels, liver). Once the virus enters, it turns the cell into a factory, making millions of copies of itself, which are then breathed or coughed out and infect others.
10 Sutras to remember
Some more numbers
{{Article_Title}}
{{Article_Author}}
{{Article_Title}}
{{Article_Author}}